Table 2.
Clinical characteristics at baseline examination for all study participants with >80% available FI-Lab21 parameters (n=500), divided by sex (n=165 and n=335, respectively) and participants lost to follow-up at 1-year follow-up after baseline examination (n=6)
| Clinical characteristics | All participants with >80% FI-Lab21 parameters (n=500) | Male participants with >80% FI-Lab21 parameters (n=165) | Female participants with >80% FI-Lab21 parameters (n=335) | P-value | Participants lost to follow-up at 1-year follow-up (n=6) |
|---|---|---|---|---|---|
| Female % (n) | 67 (335) | 0 (0) | 100 (335) | 50 (3) | |
| Age (years) | 82.8±6.2 | 82.0±6.2 | 83.2±6.2 | 0.062 | 86±4.4 |
| Height (cm) | 163.1±9.4 | 171.8±7.7 | 158.8±6.8 | <0.001 | 166.2±8.6 |
| Weight (kg) | 72.2±16.2 | 78.8±14.4 | 68.9±16.1 | <0.001 | 76.8±13.3 |
| BMI (kg/m2) | 27.1±5.6 | 26.7±4.4 | 27.3±6 | 0.664 | 27.3±5.6 |
| Unintentional weight loss >4.5 kg in last year % (n) | 36.2 (181) | 41.8 (69) | 33.4 (112) | 0.061 | 50 (3) |
| MMSE (points) | 25.5±4.3 | 25.6±4.1 | 25.5±4.4 | 0.843 | 25±3.6 |
| GDS (points) | 4.1±2.7 | 4.0±2.5 | 4.2±2.8 | 0.905 | 3.8±2.3 |
| Timed “up and go” test >19 seconds or unable to perform % (n) | 64.4 (322) | 65.5 (108) | 63.9 (214) | 0.730 | 66.7 (4) |
| Barthel Index | 68.7±20.8 | 67.4±22.7 | 69.4±19.8 | 0.593 | 53.3±20.4 |
| Heart failure % (n) | 42.8 (214) | 45.5 (75) | 41.5 (139) | 0.400 | 50 (3) |
| Peripheral vascular disease % (n) | 15.2 (76) | 19.4 (32) | 13.1 (44) | 0.067 | 16.7 (1) |
| Coronary infarction % (n) | 12.6 (63) | 20.6 (34) | 8.7 (29) | <0.001 | 16.7 (1) |
| Stroke % (n) | 21 (105) | 23 (38) | 20 (67) | 0.434 | 16.7 (1) |
| Cancer % (n) | 12 (80) | 20.6 (34) | 13.7 (46) | 0.049 | 33.3 (2) |
| Diabetes mellitus % (n) | 36.4 (182) | 43 (71) | 33.1 (111) | 0.031 | 0 (0) |
| Chronic lung disease % (n) | 20.6 (103) | 21.8 (36) | 20 (67) | 0.636 | 16.7 (1) |
| Kidney disease (%) | 56.6 (283) | 59.4 (98) | 55.2 (185) | 0.376 | 33.3 (2) |
| Urinary incontinence or catheterized % (n) | 38.2 (191) | 40 (66) | 37.3 (125) | 0.561 | 66.7 (4) |
| Constipation % (n) | 23.4 (117) | 24.8 (41) | 22.7 (76) | 0.591 | 0 (0) |
| >5 medications % (n) | 96.4 (482) | 97.6 (161) | 95.8 (321) | 0.322 | 100 (6) |
Note: Data are presented as mean ± SD (unless otherwise stated).
Abbreviations: BMI, body mass index; FI-Lab21, 21-item frailty index based on laboratory blood and urine tests; GDS, Geriatric Depression Scale; MMSE, Mini-Mental State Examination.